Novo Nordisk
NVO
NVO
1,305 hedge funds and large institutions have $27.6B invested in Novo Nordisk in 2023 Q3 according to their latest regulatory filings, with 192 funds opening new positions, 496 increasing their positions, 402 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 1,195 → 1,305 (+110)
7.97% less ownership
Funds ownership: 16.71% → 8.74% (-8%)
38% less call options, than puts
Call options by funds: $666M | Put options by funds: $1.07B
Holders
1,305
Holding in Top 10
62
Calls
$666M
Puts
$1.07B
Top Buyers
| 1 | +$696M | |
| 2 | +$134M | |
| 3 | +$120M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$109M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$88.7M |
Top Sellers
| 1 | -$221M | |
| 2 | -$99.8M | |
| 3 | -$75.4M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$63.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$59.1M |